Screener
Jade Biosciences JBIO Interest Expense
Discontinued — last reported Q1 '26
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 43,445 | 23,384 |
| Loss from operations | (43,445) | (23,384) |
| Other income (expense): | ||
| Interest income | 3,102 | 615 |
| Change in fair value of Convertible Notes payable(3) | — | (15,400) |
| Other expense | (9) | — |
| Total other income (expense), net | 3,093 | (14,785) |
| Net loss before income tax expense | (40,352) | (38,169) |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's interest expense?
- Jade Biosciences (JBIO) reported interest expense of $3.1M in Q1 2026.
- How has Jade Biosciences's interest expense changed year-over-year?
- Jade Biosciences's interest expense increased by 404.4% year-over-year, from $615K to $3.1M.
- What is the long-term trend for Jade Biosciences's interest expense?
- Over 4 years (2021 to 2025), Jade Biosciences's interest expense has grown at a 230.8% compound annual growth rate (CAGR), from $65K to $7.78M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Jade Biosciences's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude